About Triomics
Triomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like matching patients to the right clinical trials, preparing for upcoming visits, and quality reporting. We replace that manual effort with task-driven AI agents embedded directly into clinical workflows, automatically processing medical records at scale and in real time.
Our platform is trusted by 4 of the top 10 Best Hospitals for Cancer ranked by U.S. News, along with several of the largest community oncology practices. We have grown 10x over the last year and now process millions of oncology medical documents each month.
The Role
We're hiring the first member of our life sciences sales function: a quota-carrying seller focused on landing and expanding biopharma accounts. This is a build role. You will open a new commercial motion, distinct from our cancer center site deals, and own it from first outreach through closed and expanded.
Triomics builds oncology AI for the country's leading cancer centers. Our fully EMR-integrated platform turns dense patient charts into structured clinical data and matches patients to trials. We recently closed a Series B and are scaling from a handful to 25+ enterprise logos, and biopharma is a major part of where we grow next.
The best person for this role comes from a top consulting background, has spent time selling into pharma or health tech, and can hold a credible, strategic conversation with life sciences buyers about how oncology AI changes their work.
What You'll Do:
Own the biopharma sales motion end-to-end
Build pipeline and carry a quota selling Triomics into biopharma and life sciences accounts
Run the full cycle: prospecting, discovery, demos with our team, proposal, and close
Own a land-and-expand motion: land a first use case, then grow it across the account
Be strategic and credible with life sciences buyers
Translate what our oncology AI does into the language of clinical development, real-world data, and trial operations
Build relationships across the buying group: clinical, data, operations, and procurement
Bring a consultative, structured approach to complex, multi-stakeholder deals
Build the playbook
Help define pricing, packaging, and the repeatable motion for a brand-new function
Feed the market back into Product: what biopharma needs, what's landing, what's missing
Keep a clean, current pipeline and forecast
Be a force multiplier across the company
Partner with the team on deal strategy and account planning
Coordinate with the cancer center side of the business on shared accounts
What Success Looks Like (First 90 Days)
You have a qualified biopharma pipeline built and a clear view of your top targets
You're running full-cycle deals independently, with clean forecasting
You've translated the product into a biopharma value story that resonates in discovery calls
You've closed or meaningfully advanced at least one land opportunity
Leadership trusts you to own the function and represent Triomics to sophisticated buyers
Must-haves
2+ years at a top management consulting firm (MBB or similar), then roughly 1 year selling into pharma or a comparable health-tech setting
A track record of carrying and hitting a quota, or clear evidence you can
Strong consultative selling instincts: you can run a structured, multi-stakeholder enterprise deal
Credibility with sophisticated buyers: you can hold a strategic conversation about clinical development or data
High initiative and comfort building a function from zero, with no existing playbook to lean on
Excellent communication and executive presence
Comfortable being an early, quota-carrying seller reporting directly into executive leadership
Nice-to-haves
Direct experience selling into biopharma or life sciences
Familiarity with oncology, clinical trials, or real-world data
Experience at an early-stage startup building a new sales motion
Exposure to land-and-expand or enterprise expansion selling
A network across pharma clinical, data, or operations teams